08:26 AM EDT, 08/14/2026 (MT Newswires) -- Replimune ( REPL ) reported fiscal Q1 net loss Friday of $0.72 per diluted share, narrowing from a loss of $0.95 a year earlier.

Three analysts polled by FactSet expected a loss of $0.66.

As of June 30, the company said it had $195.3 million in cash, cash equivalents and short-term investments, which is expected to fund operations for more than 12 months along with the $141.0 million of net proceeds from a recently completed financing.

In addition, the company said it appointed Michelle DiNapoli as chief commercial officer, starting Aug. 18. DiNapoli joins Replimune ( REPL ) from Deciphera Pharmaceuticals, the company added.

Shares of the company were down 1.5% in Friday premarket activity.